$1.02 Billion is the total value of Slate Path Capital LP's 23 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 42.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TWTR | Sell | TWITTER INC | $169,271,000 | -35.2% | 7,050,000 | -54.5% | 16.65% | +21.2% |
| CAR | Sell | AVIS BUDGET GROUP | $112,113,000 | -13.6% | 2,555,000 | -25.1% | 11.03% | +61.5% |
| CHTR | Sell | CHARTER COMMUNICATIONS INC Ncl a | $100,788,000 | -54.2% | 300,000 | -50.4% | 9.91% | -14.3% |
| ALLY | Sell | ALLY FINL INC | $87,043,000 | -53.9% | 2,985,000 | -61.6% | 8.56% | -13.8% |
| DXC | Sell | DXC TECHNOLOGY CO | $76,869,000 | -21.1% | 810,000 | -28.6% | 7.56% | +47.5% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $56,791,000 | -13.8% | 447,000 | -20.3% | 5.58% | +61.1% |
| PODD | Sell | INSULET CORP | $38,985,000 | -74.0% | 565,000 | -79.2% | 3.83% | -51.3% |
| GDX | Sell | VANECK VECTORS ETF TRgold miners etf | $7,088,000 | -18.3% | 305,000 | -19.3% | 0.70% | +52.9% |
| DXCM | Sell | DEXCOM INC | $4,017,000 | -11.7% | 70,000 | -24.7% | 0.40% | +65.3% |
| SIL | Sell | GLOBAL X FDSglobal x silver | $3,590,000 | -51.4% | 110,000 | -50.9% | 0.35% | -9.3% |
| TRIP | Sell | TRIPADVISOR INC | $2,550,000 | -97.0% | 74,000 | -96.4% | 0.25% | -94.3% |
| IPXL | Exit | IMPAX LABORATORIES INC | $0 | – | -145,000 | -100.0% | -0.16% | – |
| SSW | Exit | SEASPAN CORP | $0 | – | -450,000 | -100.0% | -0.17% | – |
| LULU | Exit | LULULEMON ATHLETICA INC | $0 | – | -86,000 | -100.0% | -0.28% | – |
| SPY | Exit | SPDR S&P 500 ETF TRcall | $0 | – | -212,500 | -100.0% | -2.81% | – |
| CF | Exit | CF INDS HLDGS INC | $0 | – | -1,730,000 | -100.0% | -3.20% | – |
| LYV | Exit | LIVE NATION ENTERTAINMENT IN | $0 | – | -1,575,000 | -100.0% | -3.61% | – |
| AAP | Exit | ADVANCE AUTO PARTS INC | $0 | – | -1,495,000 | -100.0% | -7.80% | – |
| TIF | Exit | TIFFANY & CO NEW | $0 | – | -1,755,000 | -100.0% | -8.47% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CHARTER COMMUNICATIONS INC N | 30 | Q3 2023 | 15.2% |
| ALNYLAM PHARMACEUTICALS INC | 30 | Q3 2020 | 8.9% |
| UNITED STATES STL CORP NEW | 24 | Q3 2023 | 11.4% |
| NEW YORK TIMES CO | 23 | Q3 2023 | 10.9% |
| VANECK VECTORS ETF TR | 21 | Q3 2023 | 19.5% |
| PAN AMERN SILVER CORP | 21 | Q3 2023 | 7.6% |
| CUE BIOPHARMA INC | 17 | Q3 2023 | 1.3% |
| BARRICK GOLD CORPORATION | 16 | Q4 2020 | 15.7% |
| MOSAIC CO NEW | 15 | Q4 2021 | 16.8% |
| MEDICINES CO | 15 | Q4 2019 | 12.2% |
View Slate Path Capital LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cue Biopharma, Inc. | February 14, 2023 | 2,402,455 | 5.6% |
| Stitch Fix, Inc. | February 14, 2023 | ? | ? |
| Cyclerion Therapeutics, Inc. | January 13, 2023 | 7,157,601 | 16.5% |
| Zimmer Energy Transition Acquisition Corp. | February 14, 2022 | 2,000,000 | 5.8% |
| 5:01 Acquisition Corp. | February 11, 2022 | 500,000 | 5.8% |
| Hippo Holdings Inc. | February 11, 2022 | 350,000 | 0.1% |
| Warner Music Group Corp. | February 11, 2022 | 3,134,779 | 2.6% |
| Reinvent Technology Partners Z | February 16, 2021 | 1,750,000 | 7.6% |
View Slate Path Capital LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-01-22 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| SC 13G | 2023-02-14 |
| 13F-HR | 2023-02-14 |
| SC 13G | 2023-01-13 |
View Slate Path Capital LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.